| Key Financial Ratios of Natco Pharma (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
26.08 |
36.22 |
39.38 |
28.27 |
10.17 |
|
| Diluted EPS (Rs.) |
26.01 |
36.10 |
39.24 |
28.24 |
10.14 |
|
| Cash EPS (Rs.) |
31.46 |
40.94 |
41.39 |
31.43 |
13.03 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
212.61 |
195.24 |
169.40 |
97.40 |
76.80 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
212.61 |
195.24 |
169.40 |
97.40 |
76.80 |
|
| Dividend / Share(Rs.) |
6.75 |
6.25 |
8.25 |
6.75 |
1.25 |
|
| Revenue from Operations/Share (Rs.) |
98.36 |
108.84 |
113.35 |
112.21 |
58.70 |
|
| PBDIT/Share (Rs.) |
38.56 |
51.85 |
52.46 |
40.41 |
16.87 |
|
| PBIT/Share (Rs.) |
33.17 |
47.46 |
48.91 |
37.34 |
13.99 |
|
| PBT/Share (Rs.) |
32.04 |
46.43 |
48.11 |
36.34 |
12.73 |
|
| Net Profit/Share (Rs.) |
26.07 |
36.55 |
37.84 |
28.36 |
10.14 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
39.20 |
47.64 |
46.27 |
36.01 |
28.74 |
|
| PBIT Margin (%) |
33.72 |
43.60 |
43.14 |
33.27 |
23.83 |
|
| PBT Margin (%) |
32.57 |
42.66 |
42.44 |
32.38 |
21.68 |
|
| Net Profit Margin (%) |
26.50 |
33.58 |
33.38 |
25.27 |
17.28 |
|
| Return on Networth / Equity (%) |
12.26 |
18.72 |
22.33 |
29.11 |
13.20 |
|
| Return on Capital Employed (%) |
15.14 |
23.75 |
28.44 |
37.50 |
17.84 |
|
| Return on Assets (%) |
10.21 |
15.31 |
18.68 |
21.08 |
9.57 |
|
| Total Debt/Equity (X) |
0.08 |
0.11 |
0.06 |
0.13 |
0.07 |
|
| Asset Turnover Ratio (%) |
38.52 |
45.59 |
55.97 |
83.42 |
55.42 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.40 |
3.19 |
3.64 |
1.70 |
1.65 |
|
| Quick Ratio (X) |
2.60 |
2.48 |
2.89 |
1.15 |
0.92 |
|
| Inventory Turnover Ratio (X) |
3.41 |
3.91 |
4.91 |
5.81 |
2.90 |
|
| Dividend Payout Ratio (NP) (%) |
26.84 |
13.77 |
21.61 |
23.76 |
12.35 |
|
| Dividend Payout Ratio (CP) (%) |
22.24 |
12.29 |
19.75 |
21.44 |
9.61 |
|
| Earnings Retention Ratio (%) |
73.16 |
86.23 |
78.39 |
76.24 |
87.65 |
|
| Cash Earnings Retention Ratio (%) |
77.76 |
87.71 |
80.25 |
78.56 |
90.39 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
9,471.83 |
10,553.50 |
13,916.81 |
14,975.65 |
7,225.47 |
|
| EV/Net Operating Revenue (X) |
5.29 |
5.31 |
6.65 |
7.65 |
7.07 |
|
| EV/EBITDA (X) |
13.50 |
11.15 |
14.38 |
21.24 |
24.61 |
|
| MarketCap/Net Operating Revenue (X) |
5.15 |
5.25 |
6.65 |
7.55 |
7.02 |
|
| Retention Ratios (%) |
73.15 |
86.22 |
78.38 |
76.23 |
87.64 |
|
| Price/BV (X) |
2.38 |
2.93 |
4.45 |
8.70 |
5.37 |
|
| Price/Net Operating Revenue |
5.15 |
5.25 |
6.65 |
7.55 |
7.02 |
|
| Earnings Yield |
0.05 |
0.06 |
0.05 |
0.03 |
0.02 |
|
Source : Dion Global Solutions Limited
